ArticleAntibodies (Basel, Switzerland)2024

Integrating In Silico and In Vitro Tools for Optimized Antibody Development-Design of Therapeutic Anti-oxMIF Antibodies.

Gregor Rossmueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.